Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection

Respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in children and the elderly. However, there are no effective antiviral drugs or licensed vaccines available for RSV infection. Here, RSV virus-like particle (VLP) vaccines expressing Pre-F, G, or Pre-F and G proteins on...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su-Hwa, Chu, Ki-Back, Kim, Min-Ju, Mao, Jie, Eom, Gi-Deok, Yoon, Keon-Woong, Ahmed, Md Atique, Quan, Fu-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051362/
https://www.ncbi.nlm.nih.gov/pubmed/36986643
http://dx.doi.org/10.3390/pharmaceutics15030782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051362/
https://www.ncbi.nlm.nih.gov/pubmed/36986643
http://dx.doi.org/10.3390/pharmaceutics15030782

Ejemplares similares